Mechanisms of sulfonylurea's stimulation of insulin secretion in vivo: Selective amplification of insulin secretory burst mass

Diabetes

Volumn 45, Issue 12, 1996, Pages 1792-1797

  Pørksen, Niels K ^a   Munn, Stephen R ^a   Steers, Jeffery L ^a   Schmitz, Ole ^c   Veldhuis, Johannes D ^b   Butler, Peter C ^a,d  

^a MAYO CLINIC   (United States)

^b NATIONAL SCIENCE FOUNDATION   (United States)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; SODIUM CHLORIDE; SULFONYLUREA; TOLBUTAMIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; INSULIN BLOOD LEVEL; INSULIN CLEARANCE; INSULIN RELEASE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PANCREAS ISLET BETA CELL; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; PULSATILE HORMONE RELEASE;

EID: 0029959109     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.12.1792     Document Type: Article

References (28)

1. Franke H, Fuchs J: Ein neues antidiabetisches prinzip: ergebnisse klinischer untersuchungen. Dtsch Med Wochenschr 80:1449-1452, 1955
2. Gerich JE: Oral hypoglycemic agents. N Engl J Med 321:1231-1245, 1989
3. + channel in insulin-secreting cells. J Biol Chem 262:15840-15844, 1987
4. 2+-dependent phosphorylation of three proteins concomitant with insulin secretion from HIT cells. Diabetes 36:864-871, 1987
5. Goodner CJ, Walike BC, Koerker DJ, Ensinck JW, Brown AC, Chideckel EW, Palmer J, Kalnasy L: Insulin, glucagon, and glucose exhibit synchronous, sustained oscillations in fasting monkeys. Science 195:177-179, 1977
6. Lang DA, Matthews DR, Peto J, Turner RC: Cyclic oscillation of basal plasma glucose and insulin concentrations in human beings. N Engl J Med 301:1023-1027, 1979
7. Pørksen N, Munn S, Steers J, Vore S, Veldhuis J, Butler PC: Pulsatile insulin secretion accounts for 70% of total insulin secreted during fasting. Am J Physiol 269 (Endocrinol Metab 32):E478-E488, 1995
8. Marchetti P, Scharp DW, Mclear M, Gingerich R, Finke E, Olack B, Swanson C, Giannarelli R, Navalesi R, Lacy PE: Pulsatile insulin secretion from isolated human pancreatic islets. Diabetes 43:827-830, 1994
9. Pørksen N, Munn S, Steers J, Veldhuis J, Butler PC: Impact of sampling technique on appraisal of pulsatile insulin secretion by deconvolution and cluster analysis. Am J Physiol 269:E1106-E1114, 1995
10. Veldhuis JD, Johnson ML: Deconvolution analysis of endocrine data. Methods Enzymol 210:539-575, 1992
11. Skillman TG, Feldman JM: The pharmacology of sulfonylureas. Am J Med 70:361-372, 1981
12. Pørksen N, Munn S, Ferguson D, O'Brien T, Veldhuis J, Butler PC: Coordinate pulsatile insulin secretion by chronic intraportally transplanted islets in the isolated perfused rat liver. J Clin Invest 94:219-227, 1994
13. Grodsky GM, Epstein GH, Fanska R, Karam JH: Pancreatic action of sulfonyl-ureas. Fed Proc 36:2714-2719, 1977
14. Boyd AE III, Aguilar-Bryan L, Bryan J, Kunze DL, Moss L, Nelson DA, Rajan AS, Raef H, Xiang HD, Yaney GC: Sulfonylurea signal transduction. Recent Prog Harm Res 47:299-316, 1991
15. 2+, oxygen consumption, and insulin secretion in glucose-stimulated rat pancreatic islets. J Biol Chem 266:9314-9319, 1991
16. Lang DA, Matthews DR, Turner RC: Brief, irregular oscillations of basal plasma insulin and glucose concentrations in diabetic man. Diabetes 30:435-439, 1981
17. O'Rahilly S, Turner RC, Matthews DR: Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med 318:1225-1230, 1988
18. Almer L-O, Johansson E, Melander A, Wahlin-Boll E: Influence of sulphonylureas on the secretion, disposal, and effect of insulin. Eur J Clin Pharmacol 22:27-32, 1982
19. Scheen AJ, Lefebvre PJ, Loyckx AS: Glipizide increases plasma insulin but not C-peptide levels after a standardized breakfast in type 2 diabetic patients. Eur J Clin Pharmacol 26:471-474, 1984
20. Groop L, Groop PH, Stenman S, Saloranta C, Totterman KJ, Fyhrquist F, Melander A: Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatment. Diabetes Care 10:71-78, 1987
21. Widen E: Does glibenclamide influence the clearance of insulin and glucose uptake in patients with type 2 diabetes mellitus? Scand J Clin Lab Invest 53:395-403, 1993
22. Lewis GF, Steiner G, Polonsky KS, Weller B, Zinman B: A new method for comparing portal and peripheral venous insulin delivery in humans: tolbutamide versus insulin infusion. J Clin Endocrinol Metab 79:66-70, 1994
23. Polonsky K, Frank B, Pugh W, Addis A, Karrison T, Meier P, Tager H, Rubenstein A: The limitations to and valid use of C-peptide as a marker of the secretion of insulin. Diabetes 35:379-386, 1986
24. Polonsky KS, Gumbiner B, Ostrega D, Griver K, Tager H, Henry RR: Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM. Diabetes 43:871-877, 1994
25. Storch MJ, Rossle M, Kerp L: Pulsatile insulin secretion into the portal vein in liver cirrhosis. Dtsch Med Wochenschr 118:134-138, 1993
26. Pørksen N, Munn S, Steers J, Veldhuis JD, Butler PC: Effects of glucose ingestion versus infusion on pulsatile insulin secretion: the incretin effect is achieved by amplification of insulin secretory burst mass. Diabetes 45:1317-1323, 1996
27. Paolisso G, Sgambato S, Torella R, Varricchio M, Scheen A, D'Onofrio F, Lefebvre PJ: Pulsatile insulin delivery is more efficient than continuous infusion in modulating islet cell function in normal subjects and patients with type I diabetes. J Clin Endocrinol Metab 66:1220-1226, 1988
28. Matthews DR, Naylor BA, Jones RG, Ward GM, Turner RC: Pulsatile insulin has greater hypoglycemic effect than continuous delivery. Diabetes 32:617-621, 1993